Legacy App users can now access the Health Portal – just reset your password using email as username.

Join

How I Manage Men on Testosterone Replacement Therapy (TRT)

How I Manage Men on Testosterone Replacement Therapy (TRT)

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
A practical management overview is given, focusing on individualized decisions and safer monitoring habits. The goal is building a repeatable plan rather than chasing numbers or internet protocols.
02:14
The segment outlines a first visit TRT intake, including symptoms, goals, and prior androgen exposure. A structured baseline is emphasized so later adjustments are made with context and documentation.
04:29
A practical management overview is given, focusing on individualized decisions and safer monitoring habits. The goal is building a repeatable plan rather than chasing numbers or internet protocols.
06:16
Attention shifts to labs, stressing timing, trends, and why single values can mislead decisions. Markers like hematocrit, lipids, estradiol, and PSA are discussed as monitoring priorities.
08:18
Dosing strategy is discussed with an emphasis on frequency, consistency, and minimizing sharp peaks. Smaller, repeated injections are framed as a way to reduce swings in mood and side effects.
10:07
Common side effects are reviewed, including acne, water retention, and possible gynecomastia concerns. Risk reduction is framed around conservative titration and early response to warning signs.
12:09
A practical management overview is given, focusing on individualized decisions and safer monitoring habits. The goal is building a repeatable plan rather than chasing numbers or internet protocols.
13:49
Attention shifts to labs, stressing timing, trends, and why single values can mislead decisions. Markers like hematocrit, lipids, estradiol, and PSA are discussed as monitoring priorities.

Video Summary

The discussion presents a clinician’s approach to managing men on testosterone replacement therapy in real practice. Rather than starting with dosing, the approach begins with clarifying the chief complaint and goals for treatment. Symptoms, prior androgen exposure, and medical history are framed as essential context for safe decisions. Baseline vitals and risk factors are emphasized so preventable problems are not missed early. The conversation encourages documenting expectations, because TRT is not a quick fix for every concern. A structured intake is positioned as the foundation for later adjustments that remain rational. The overall theme is individualized care supported by consistent data and honest symptom reporting.

Lab monitoring is discussed as a repeating process rather than a one time gatekeeping step. Timing is emphasized because injections can distort results when blood is drawn too close to a dose. Trending markers over time is framed as more useful than chasing an isolated number. Key labs mentioned include hematocrit, lipid panels, estradiol when indicated, and prostate related screening. Dosing frequency is also discussed, with smaller and more consistent injections described as a stability strategy. Side effects like acne, water retention, and breast tissue concerns are framed as signals to reassess the plan. The message is to adjust conservatively and measure outcomes rather than making dramatic swings.

Fertility planning is raised because TRT can reduce sperm production and change reproductive goals quickly. When fertility matters, alternatives and adjuncts are discussed as options that require clinician supervision. Follow up cadence is described as central, especially after starting therapy or changing a protocol. Consistent intervals for rechecks are encouraged so comparisons reflect true changes rather than timing noise. Cardiometabolic risk is revisited through blood pressure, sleep quality, and long term cholesterol management. Lifestyle fundamentals are presented as necessary partners, including nutrition consistency and conditioning work. The closing reinforces that safer TRT management combines structure, restraint, and ongoing monitoring.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone medication used for clinically indicated testosterone replacement therapy in men. The transcript focuses on TRT management, including dosing consistency and monitoring priorities.
Clomiphene
Clomiphene is a selective estrogen receptor modulator used to stimulate endogenous gonadotropin signaling in some men. The transcript references clomiphene as a fertility focused option when testosterone suppression is a concern.

Condition Callouts

Condition
Description
Gynecomastia
Gynecomastia is benign enlargement of male breast glandular tissue, often related to hormonal imbalance. The transcript mentions gynecomastia as a possible concern that should prompt reassessment of management.
Sleep apnea
Sleep apnea is repeated breathing interruption during sleep that lowers oxygen and increases cardiometabolic strain. The transcript mentions sleep quality as part of overall risk management while on testosterone therapy.
Erythrocytosis
Erythrocytosis is increased red blood cell mass that can raise hematocrit and increase viscosity concerns. The transcript references hematocrit monitoring as an important lab trend in TRT management.
Benign prostatic hyperplasia
Benign prostatic hyperplasia is noncancerous enlargement of the prostate that can cause urinary symptoms. The transcript references prostate monitoring considerations as part of long term TRT safety planning.
Prostate cancer
Prostate cancer is malignant growth of prostate cells that can progress locally or spread if untreated. The transcript references prostate screening and PSA monitoring as part of risk assessment on TRT.
Acne
Acne is an inflammatory skin condition that can worsen with androgen exposure in susceptible individuals. The transcript mentions acne as a side effect signal that may require dose or strategy adjustment.

Key Takeaways

  • A structured intake is emphasized so TRT decisions match symptoms and goals.
  • Lab timing and trend monitoring are framed as more important than one value.
  • Consistent dosing frequency is described as a way to reduce hormonal swings.
  • Side effects should trigger conservative reassessment rather than reckless escalation.
  • Follow up cadence and lifestyle basics are presented as central to safer TRT care.

More Videos

Previous Video:
Next Video: